河北医药
河北醫藥
하북의약
HEBEI MEDICAL JOURNAL
2014年
10期
1463-1465
,共3页
结直肠肿瘤%CD105%临床病理特征%微血管密度
結直腸腫瘤%CD105%臨床病理特徵%微血管密度
결직장종류%CD105%림상병리특정%미혈관밀도
colorectal carcinoma%CD105%clinicopathologic factors%microvessel density
目的:分析CD105在结直肠癌组织中的表达并探讨其与血管生成的关系。方法应用免疫组织化学方法检测60例原发性结直肠癌组织、20例结直肠腺瘤组织、10例结直肠黏膜组织中CD105的表达。结果60例结直肠癌标本平均微血管计数为(30±8)条。结直肠癌CD105标记的MVD值明显高于结直肠腺瘤组织( P <0浇.01)。CD105标记的MVD值与肿瘤分期、淋巴结转、远处转移明显差异有统计学意义( P <0.01),而与患者的年龄、性别、肿瘤直径、大体类型、病理类型及组织学分级均差异无统计学意义( P >0.05)。结论 MVD在TNM分期、淋巴结转移情况和远处转移情况有明显差异,提示CD105表达密度增强的患者浸润转移率高、预后差。
目的:分析CD105在結直腸癌組織中的錶達併探討其與血管生成的關繫。方法應用免疫組織化學方法檢測60例原髮性結直腸癌組織、20例結直腸腺瘤組織、10例結直腸黏膜組織中CD105的錶達。結果60例結直腸癌標本平均微血管計數為(30±8)條。結直腸癌CD105標記的MVD值明顯高于結直腸腺瘤組織( P <0澆.01)。CD105標記的MVD值與腫瘤分期、淋巴結轉、遠處轉移明顯差異有統計學意義( P <0.01),而與患者的年齡、性彆、腫瘤直徑、大體類型、病理類型及組織學分級均差異無統計學意義( P >0.05)。結論 MVD在TNM分期、淋巴結轉移情況和遠處轉移情況有明顯差異,提示CD105錶達密度增彊的患者浸潤轉移率高、預後差。
목적:분석CD105재결직장암조직중적표체병탐토기여혈관생성적관계。방법응용면역조직화학방법검측60례원발성결직장암조직、20례결직장선류조직、10례결직장점막조직중CD105적표체。결과60례결직장암표본평균미혈관계수위(30±8)조。결직장암CD105표기적MVD치명현고우결직장선류조직( P <0요.01)。CD105표기적MVD치여종류분기、림파결전、원처전이명현차이유통계학의의( P <0.01),이여환자적년령、성별、종류직경、대체류형、병리류형급조직학분급균차이무통계학의의( P >0.05)。결론 MVD재TNM분기、림파결전이정황화원처전이정황유명현차이,제시CD105표체밀도증강적환자침윤전이솔고、예후차。
Objective To investigate the expression of CD 105 in colorectal carcinoma and to explore the relationship between the expression and angiogenesis .Methods Immunohistochemistry was used to detect the expression of CD 105 in 60 cases of primary colorectal carcinomas ,20 cases of colorectal adenomas and 10 cases of normal colorectal tissues .Results The average microvessel number labeled with CD 105 in 60 cases of colorectal carcinoma was 30 ±8.The MVD value in primary colorectal carcinomas labeled with CD 105 was significantly higher than that in colorectal adenomas ( P <0.01),which was closely related to TNM stage,lymph node metastasis and distant metastasis ( P <0.01),however,which was not correlated with patient’s sex and age,the tumor’s size,histological type,pathological type and the degree of differentiation ( P >0.05). Conclusion MVD has significant differences at the respects of TNM stage ,lymph node metastasis and distant metastasis, which suggests that the patients with enhancement of CD 105 expression density have higher rates of tumor metastasis and poorer prognosis .